DataMeds AI, Inc

MEDS Healthcare Pharmaceutical Retailers

DataMeds AI, Inc’s revenue for fiscal 2025 (year ended December 2025) was $23.3 million, up 28.7% from fiscal 2024. In the quarter to June 2026, revenue fell 77.2%, EPS fell 29.6%, free cash flow fell 41.9% and total debt fell 15.4%, each against the same quarter a year earlier.

2.63 0.22 −7.72%
Market cap
$12.8M
P/E
0.0×
Fwd P/E
—
Dividend yield
0.00%
F-score
n/a
Altman Z
−15.16
Beneish M
n/a
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
ROE
949.27% 1,447.25% 3,545.16% (4,010.50%)

+7 more TTM periods

ROA
(202.97%) (173.68%) (230.71%) (292.76%)
ROIC
0.00% (702.13%) (532.81%) (143.70%)
Return on Tangible Assets
262.67% 261.96% 378.86% 395.66%
Average Days of Receivables
54.61 25.91 17.79 11.78
Free Cash Flow per Share
(5.69) (6.56) (8.27) (5.07)
Free Cash Flow
(14.66) (13.73) (11.74) (7.55)
Other line items

Show all line items

Columns are period end dates